<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               2  DOSAGE AND ADMINISTRATION<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Initial, Target and Maximum Daily Dose (2.1)<BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="t_hltdostab" width="100%"><BR>                           <colgroup align="left" char="." charoff="50"><BR>                              <col align="left" char="." charoff="50"/><BR>                              <col align="left" char="." charoff="50"/><BR>                              <col align="left" char="." charoff="50"/><BR>                              <col align="left" char="." charoff="50"/><BR>                           </colgroup><BR>                           <tbody valign="top"><BR>                              <tr valign="top"><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Body Weight</content><BR>                                    </paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Initial Daily Dose</content><BR>                                    </paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Target Total Daily Dose</content><BR>                                    </paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Maximum Total Daily Dose</content><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr valign="top"><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>Children and<BR>adolescents up to 70&#160;kg</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>0.5&#160;mg/kg</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>1.2&#160;mg/kg</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>1.4&#160;mg/kg</paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr valign="top"><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>Children and<BR>adolescents over 70&#160;kg and adults</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>40&#160;mg</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>80&#160;mg</paragraph><BR>                                 </td><BR>                                 <td align="left" char="." charoff="50" valign="top"><BR>                                    <paragraph>100&#160;mg</paragraph><BR>                                 </td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Dosing adjustment — Hepatic Impairment, Strong CYP2D6 Inhibitor, and in patients known to be CYP2D6 poor metabolizers (PMs). (2.4,<BR>                            12.3)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.1  Acute Treatment<BR>                     <BR>                        <BR>                           Dosing<BR>of children and adolescents up to 70 kg body weight — STRATTERA should<BR>be initiated at a total daily dose of approximately 0.5 mg/kg<BR>and increased after a minimum of 3 days to a target total<BR>daily dose of approximately 1.2 mg/kg administered either<BR>as a single daily dose in the morning or as evenly divided doses in the morning<BR>and late afternoon/early evening. No additional benefit has been demonstrated<BR>for doses higher than 1.2 mg/kg/day <BR>                              [see Clinical<BR>Studies (14)]<BR>                           .<BR>                        The total daily dose in children and adolescents should not<BR>exceed 1.4 mg/kg or 100 mg, whichever is<BR>less.<BR>                        <BR>                           Dosing<BR>of children and adolescents over 70 kg body weight and adults — STRATTERA should<BR>be initiated at a total daily dose of 40 mg and increased<BR>after a minimum of 3 days to a target total daily dose of<BR>approximately 80 mg administered either as a single daily<BR>dose in the morning or as evenly divided doses in the morning and late afternoon/early<BR>evening. After 2 to 4 additional<BR>weeks, the dose may be increased to a maximum of 100 mg in<BR>patients who have not achieved an optimal response. There are no data that<BR>support increased effectiveness at higher doses <BR>                              [see Clinical<BR>Studies (14)]<BR>                           .<BR>                        The maximum recommended total daily dose in children and adolescents<BR>over 70 kg and adults is 100 mg.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.2  Maintenance/Extended Treatment<BR>                     <BR>                        <BR>                             It is generally agreed that pharmacological treatment of ADHD may be needed for extended periods. The benefit of maintaining pediatric patients (ages 6-15 years) with ADHD on STRATTERA after achieving a response in a dose range of 1.2 to 1.8 mg/kg/day was demonstrated in a controlled trial. Patients assigned to STRATTERA in the maintenance phase were generally continued on the same dose used to achieve a response in the open label phase. The physician who elects to use STRATTERA for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient <BR>                                 [see Clinical Studies (14.1)].<BR>                           <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.3  General Dosing Information<BR>                     <BR>                        STRATTERA may<BR>be taken with or without food.<BR>                        STRATTERA can<BR>be discontinued without being tapered.<BR>                        STRATTERA capsules are not intended to be opened,<BR>they should be taken whole <BR>                              [see Patient Counseling Information (17.6)].<BR>                           <BR>                        <BR>                        The safety of single doses over 120 mg and<BR>total daily doses above 150 mg have not been systematically<BR>evaluated.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.4  Dosing in Specific Populations<BR>                     <BR>                        <BR>                           Dosing<BR>adjustment for hepatically impaired patients — For those<BR>ADHD patients who have hepatic insufficiency (HI), dosage adjustment is recommended<BR>as follows: For patients with moderate HI (Child–Pugh<BR>Class B), initial and target doses should be reduced to 50% of<BR>the normal dose (for patients without HI). For patients with severe HI (Child–Pugh<BR>Class C), initial dose and target doses should be reduced<BR>to 25% of normal <BR>                              [see Use In Specific Populations<BR>(8.6)]<BR>                           .<BR>                        <BR>                           Dosing<BR>adjustment for use with a strong CYP2D6 inhibitor or in patients who are known to be CYP2D6 PMs — In children<BR>and adolescents up to 70 kg body weight administered strong<BR>CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and quinidine, or in patients who are known to be CYP2D6 PMs, STRATTERA should<BR>be initiated at 0.5 mg/kg/day and only increased to the usual<BR>target dose of 1.2 mg/kg/day if symptoms fail to improve<BR>after 4 weeks and the initial dose is well tolerated.<BR>                        In children and adolescents over 70 kg body<BR>weight and adults administered strong CYP2D6 inhibitors, e.g., paroxetine,<BR>fluoxetine, and quinidine, STRATTERA should<BR>be initiated at 40 mg/day and only increased to the usual<BR>target dose of 80 mg/day if symptoms fail to improve after<BR>4 weeks and the initial dose is well tolerated.<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>